Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $85,832 | 7 | 95.3% |
| Food and Beverage | $2,866 | 37 | 3.2% |
| Travel and Lodging | $1,410 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $85,878 | 8 | $0 (2024) |
| Janssen Research & Development, LLC | $1,668 | 8 | $0 (2017) |
| LivaNova USA, Inc. | $550.24 | 6 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $414.21 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $370.69 | 3 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $238.99 | 2 | $0 (2024) |
| ABBVIE INC. | $227.40 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $176.43 | 2 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $124.26 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $115.06 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,763 | 9 | Gilead Sciences, Inc. ($19,954) |
| 2023 | $3,283 | 8 | Gilead Sciences, Inc. ($2,629) |
| 2022 | $9,397 | 4 | Gilead Sciences, Inc. ($9,174) |
| 2021 | $8,208 | 1 | Gilead Sciences, Inc. ($8,208) |
| 2020 | $8,245 | 2 | Gilead Sciences, Inc. ($8,161) |
| 2019 | $7,018 | 7 | Gilead Sciences, Inc. ($6,467) |
| 2018 | $194.74 | 4 | Janssen Pharmaceuticals, Inc ($95.69) |
| 2017 | $33,000 | 11 | Gilead Sciences Inc ($31,238) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $19,954.00 | General |
| 11/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.26 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/07/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $141.94 | General |
| Category: Neurology | ||||||
| 07/09/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $76.56 | General |
| Category: Neurology | ||||||
| 07/09/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: Neurology | ||||||
| 05/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $95.42 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $127.28 | General |
| Category: PSYCHIATRY | ||||||
| 03/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $111.71 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $96.88 | General |
| Category: Neurology | ||||||
| 12/31/2023 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,629.00 | General |
| 10/18/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Neuroscience | ||||||
| 10/03/2023 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $95.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $80.58 | General |
| Category: Central Nervous System | ||||||
| 06/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: PSYCHIATRY | ||||||
| 05/31/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $78.04 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $114.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $109.69 | General |
| Category: Neuropsychiatry | ||||||
| 12/31/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,174.32 | General |
| 11/30/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $71.28 | General |
| Category: Neuropsychiatry | ||||||
| 06/01/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $45.56 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2022 | LivaNova USA, Inc. | VNS Therapy Symmetry Model 8103 Generator (Device) | Food and Beverage | In-kind items and services | $105.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/31/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,207.99 | General |
| 12/31/2020 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,161.21 | General |
| 02/25/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $83.92 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2019 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,467.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 63 | 100 | $10,712 | $6,165 |
| 2022 | 4 | 80 | 135 | $17,787 | $9,815 |
| 2021 | 3 | 65 | 87 | $14,209 | $7,381 |
| 2020 | 5 | 93 | 137 | $19,751 | $9,134 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 67 | $8,048 | $4,327 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 33 | $2,664 | $1,838 | 69.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 44 | 90 | $11,208 | $6,654 | 59.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 17 | $2,800 | $1,340 | 47.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 15 | $2,692 | $1,220 | 45.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 11 | 13 | $1,087 | $600.95 | 55.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 36 | $5,760 | $2,820 | 49.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 26 | 38 | $4,458 | $2,651 | 59.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $3,991 | $1,910 | 47.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 25 | 48 | $5,829 | $2,555 | 43.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 28 | $4,467 | $2,351 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $4,019 | $1,783 | 44.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 14 | 23 | $3,151 | $1,464 | 46.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 22 | 25 | $2,285 | $981.78 | 43.0% |
About Dr. Anita Kablinger, M.D
Dr. Anita Kablinger, M.D is a Psychiatry healthcare provider based in Roanoke, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104859214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anita Kablinger, M.D has received a total of $90,108 in payments from pharmaceutical and medical device companies, with $20,763 received in 2024. These payments were reported across 46 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($85,832).
As a Medicare-enrolled provider, Kablinger has provided services to 301 Medicare beneficiaries, totaling 459 services with total Medicare billing of $32,495. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Roanoke, VA
- Active Since 07/09/2006
- Last Updated 03/21/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1104859214
Products in Payments
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $444.90
- INGREZZA (Drug) $414.21
- CAPLYTA (Drug) $310.78
- SPRAVATO (Drug) $305.71
- FANAPT (Drug) $124.26
- LATUDA (Drug) $115.06
- VRAYLAR (Drug) $114.50
- Mavyret (Drug) $112.90
- VNS Therapy Symmetry Model 8103 Generator (Device) $105.34
- AUSTEDO (Drug) $95.85
- INVEGA TRINZA (Drug) $95.69
- Auvelity (Drug) $95.42
- ABILIFY MAINTENA (Drug) $94.09
- Austedo XR (Drug) $80.58
- Dyanavel XR (Drug) $20.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Roanoke
Dr. David Scheiderer, M.d, M.D
Psychiatry — Payments: $2.7M
Mr. Ralph Mckenzie, D.o, D.O
Psychiatry — Payments: $137,557
Dr. Robert Murdock, M.d, M.D
Psychiatry — Payments: $5,262
Dr. Khoa Tran, Md, MD
Psychiatry — Payments: $3,810
Roopa Sethi, M.d, M.D
Psychiatry — Payments: $2,317
Dr. Richard Linsk, Md, Phd, MD, PHD
Psychiatry — Payments: $2,212